Sector: health
Conviction from: NASDAQ
Develops, manufactures and markets DNA sequencing and array-based systems, consumables and software used in genomic research and clinical diagnostics.
3 tracked filer(s) hold this · 1 opened, 0 added, 1 trimmed in 31-MAR-2026
Aggregate 13FScore 55 — mean of 3 scored holder(s) · buyers (new/add) avg 55. Higher = the smart money in this name has the better track record.
Beyond 13F — activists, insiders, politicians & research
1 disclosed trade(s) by 1 filer(s).
2 disclosed trade(s) by 1 filer(s).